Aspen Aerogels Stock Forecast, Price & News

-1.67 (-4.34 %)
(As of 07/27/2021 11:40 AM ET)
Today's Range
50-Day Range
52-Week Range
Volume2,016 shs
Average Volume314,053 shs
Market Capitalization$1.04 billion
P/E RatioN/A
Dividend YieldN/A
30 days | 90 days | 365 days | Advanced Chart
Receive ASPN News and Ratings via Email

Sign-up to receive the latest news and ratings for Aspen Aerogels and its competitors with MarketBeat's FREE daily newsletter.

Aspen Aerogels logo

About Aspen Aerogels

Aspen Aerogels, Inc. designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and building materials markets in the United States, Asia, Canada, Europe, and Latin America. The company offers PyroThin thermal barriers for use in lithium-ion batteries in electric vehicles and energy grid industries; Pyrogel XTE that reduces the risk of corrosion under insulation in energy infrastructure operating systems; Pyrogel HPS for applications within the power generation market; Pyrogel XTF to provide protection against fire; Cryogel Z for sub-ambient and cryogenic applications in the energy infrastructure market; and Spaceloft Subsea for use in pipe-in-pipe applications in offshore oil production. It also offers Spaceloft Grey and Spaceloft A2 for use in the building materials market; and Cryogel X201, which is used in designing cold systems, such as refrigerated appliances, cold storage equipment, and aerospace systems. Aspen Aerogels, Inc. was founded in 2001 and is headquartered in Northborough, Massachusetts.


See More Headlines

Industry, Sector and Symbol

Sales & Book Value






Overall MarketRank

1.48 out of 5 stars

Construction Sector

90th out of 215 stocks

Lumber & Other Construction Materials Industry

4th out of 7 stocks

Analyst Opinion: 2.5Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.6 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

Aspen Aerogels (NYSE:ASPN) Frequently Asked Questions

Is Aspen Aerogels a buy right now?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Aspen Aerogels in the last year. There are currently 7 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Aspen Aerogels stock.
View analyst ratings for Aspen Aerogels
or view top-rated stocks.

What stocks does MarketBeat like better than Aspen Aerogels?

Wall Street analysts have given Aspen Aerogels a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Aspen Aerogels wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Aspen Aerogels?

Aspen Aerogels saw a decline in short interest in July. As of July 15th, there was short interest totaling 713,800 shares, a decline of 26.2% from the June 30th total of 967,200 shares. Based on an average daily volume of 261,700 shares, the short-interest ratio is currently 2.7 days. Currently, 2.7% of the shares of the company are sold short.
View Aspen Aerogels' Short Interest

When is Aspen Aerogels' next earnings date?

Aspen Aerogels is scheduled to release its next quarterly earnings announcement on Thursday, July 29th 2021.
View our earnings forecast for Aspen Aerogels

How can I listen to Aspen Aerogels' earnings call?

Aspen Aerogels will be holding an earnings conference call on Thursday, July 29th at 5:00 PM Eastern. Interested parties can register for or listen to the call using this link.

How were Aspen Aerogels' earnings last quarter?

Aspen Aerogels, Inc. (NYSE:ASPN) issued its quarterly earnings results on Wednesday, April, 28th. The construction company reported ($0.22) earnings per share for the quarter, missing the consensus estimate of ($0.20) by $0.02. The construction company earned $28.10 million during the quarter, compared to analyst estimates of $23.45 million. Aspen Aerogels had a negative net margin of 24.90% and a negative trailing twelve-month return on equity of 38.01%.
View Aspen Aerogels' earnings history

How has Aspen Aerogels' stock price been impacted by Coronavirus (COVID-19)?

Aspen Aerogels' stock was trading at $6.50 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, ASPN stock has increased by 472.3% and is now trading at $37.20.
View which stocks have been most impacted by COVID-19

What guidance has Aspen Aerogels issued on next quarter's earnings?

Aspen Aerogels updated its FY 2021 earnings guidance on Thursday, May, 6th. The company provided earnings per share (EPS) guidance of -1.140--1.010 for the period, compared to the Thomson Reuters consensus estimate of $-0.790. The company issued revenue guidance of $103 million-$111 million, compared to the consensus revenue estimate of $104.50 million.

What price target have analysts set for ASPN?

7 brokerages have issued 1 year price targets for Aspen Aerogels' stock. Their forecasts range from $11.00 to $45.00. On average, they expect Aspen Aerogels' share price to reach $36.64 in the next year. This suggests that the stock has a possible downside of 1.5%.
View analysts' price targets for Aspen Aerogels
or view top-rated stocks among Wall Street analysts.

Who are Aspen Aerogels' key executives?

Aspen Aerogels' management team includes the following people:
  • Mr. Donald R. Young, Pres, CEO & Director (Age 64, Pay $517.27k)
  • Mr. John F. Fairbanks, VP, CFO, Principal Accounting Officer & Treasurer (Age 60, Pay $302.5k)
  • Mr. Corby C. Whitaker, Sr. VP of Sales & Marketing (Age 51, Pay $326.75k)
  • Mr. Gregg R. Landes, Sr. VP of Operations & Strategic Devel. (Age 51)
  • Dr. George L. Gould, Chief Technology Officer (Age 58)
  • Ms. Kelley W. Conte, Sr. VP of HR (Age 56)
  • Mr. Jeffrey Alan Ball, Advisor (Age 53)
  • Mr. Sahir C. Surmeli, Sec.

What is Donald R. Young's approval rating as Aspen Aerogels' CEO?

5 employees have rated Aspen Aerogels CEO Donald R. Young on Glassdoor.com. Donald R. Young has an approval rating of 100% among Aspen Aerogels' employees. This puts Donald R. Young in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of Aspen Aerogels' key competitors?

What other stocks do shareholders of Aspen Aerogels own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Aspen Aerogels investors own include Intelsat (I), Gilead Sciences (GILD), Bank of America (BAC), AMC Entertainment (AMC), Fossil Group (FOSL), Associated British Foods (ABF), Apollo Global Management (APO), Chaarat Gold (CGH), China Unicom (Hong Kong) (CHU) and Ciena (CIEN).

What is Aspen Aerogels' stock symbol?

Aspen Aerogels trades on the New York Stock Exchange (NYSE) under the ticker symbol "ASPN."

Who are Aspen Aerogels' major shareholders?

Aspen Aerogels' stock is owned by many different institutional and retail investors. Top institutional investors include Harel Insurance Investments & Financial Services Ltd. (0.09%) and Taylor Cottrill Erickson & Associates Inc. (0.03%). Company insiders that own Aspen Aerogels stock include Corby C Whitaker, Donald R Young and Kelley Conte.
View institutional ownership trends for Aspen Aerogels

Which institutional investors are buying Aspen Aerogels stock?

ASPN stock was purchased by a variety of institutional investors in the last quarter, including Harel Insurance Investments & Financial Services Ltd., and Taylor Cottrill Erickson & Associates Inc..
View insider buying and selling activity for Aspen Aerogels
or or view top insider-buying stocks.

How do I buy shares of Aspen Aerogels?

Shares of ASPN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Aspen Aerogels' stock price today?

One share of ASPN stock can currently be purchased for approximately $37.20.

How much money does Aspen Aerogels make?

Aspen Aerogels has a market capitalization of $1.05 billion and generates $100.27 million in revenue each year. The construction company earns $-21,810,000.00 in net income (profit) each year or ($0.83) on an earnings per share basis.

How many employees does Aspen Aerogels have?

Aspen Aerogels employs 290 workers across the globe.

What is Aspen Aerogels' official website?

The official website for Aspen Aerogels is www.aerogel.com.

Where are Aspen Aerogels' headquarters?

Aspen Aerogels is headquartered at 30 FORBES ROAD BUILDING B, NORTHBOROUGH MA, 01532.

How can I contact Aspen Aerogels?

Aspen Aerogels' mailing address is 30 FORBES ROAD BUILDING B, NORTHBOROUGH MA, 01532. The construction company can be reached via phone at 508-691-1111 or via email at [email protected]

This page was last updated on 7/27/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.